Pioneering commercial CAR T cell therapy clinical development in India and South Asia

Cell & Gene Therapy Insights 2021; 7(10), 1269–1274


Published: 22 October 2021
Anil Kamat

Anil Kamat is a recognized clinical leader in hematology, with extensive experience in both clinical and manufacturing contexts. He is head of clinical development at Immuneel Therapeutics, based in Bengaluru, India, and serves as a consultant hematologist for the UK National Health Service. Dr Kamat is a member and contributor to several societies, including the International Society for Cell and Gene Therapy, the American Society of Hematology, and the European Group for Blood and Marrow Transplantation.